5-HT3 RECEPTORS - PHARMACOLOGICAL AND THERAPEUTIC ASPECTS

被引:55
作者
GYERMEK, L
机构
[1] Department of Anesthesiology, Harbor-UCLA Medical Center, Torrance, CA 90509
关键词
D O I
10.1002/j.1552-4604.1995.tb04129.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The serotonin 5-HT, receptor is unique among the seven serotonin receptor ''families'' that have been recognized so far. It functions nor as a G-protein coupled but as a direct ion channel gated receptor. Because of the varied neural functions linked to this receptor, intensive research interest has developed in recent years about its basic and clinical pharmacology, which are summarized in this review. Some new agonists and many new antagonists have been developed. These agents have a useful role as selective pharmacologic research probes, and some of them con be used therapeutically as potent and selective antinausea and antiemetic drugs, particularly in patients undergoing cancer chemotherapy treatment or general anesthesia procedures. Potential applications of these agents include the treatment of some behavioral disorders in mental disease, drug addiction, and certain types of pain syndromes.
引用
收藏
页码:845 / 855
页数:11
相关论文
共 100 条
[1]   5-HT3 RECEPTOR ANTAGONISTS - AN OVERVIEW OF THEIR PRESENT STATUS AND FUTURE POTENTIAL IN CANCER THERAPY-INDUCED EMESIS [J].
AAPRO, MS .
DRUGS, 1991, 42 (04) :551-568
[2]  
ALHAIDER AA, 1991, J NEUROSCI, V11, P1881
[3]   REMISSION OF SYMPTOMS IN CARCINOID-SYNDROME WITH A NEW 5-HYDROXYTRYPTAMINE M-RECEPTOR ANTAGONIST [J].
ANDERSON, JV ;
COUPE, MO ;
MORRIS, JA ;
HODGSON, HJF ;
BLOOM, SR .
BRITISH MEDICAL JOURNAL, 1987, 294 (6580) :1129-1129
[4]   NEUROPHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER THERAPY [J].
ANDREWS, PLR ;
RAPEPORT, WG ;
SANGER, GJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (09) :334-341
[5]   FUNCTIONAL-CHARACTERIZATION OF 5-HT3-LIKE RECEPTORS IN THE RAT MEDIAL PREFRONTAL CORTEX - BIOCHEMICAL AND ELECTROPHYSIOLOGICAL STUDIES [J].
ASHBY, CR ;
EDWARDS, E ;
MINABE, Y ;
WANG, RY .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (05) :1958-1959
[6]   CHARACTERIZATION AND AUTORADIOGRAPHIC LOCALIZATION OF 5-HT3 RECEPTOR RECOGNITION SITES IDENTIFIED WITH [3H]-(S)-ZACOPRIDE IN THE FOREBRAIN OF THE RAT [J].
BARNES, JM ;
BARNES, NM ;
CHAMPANERIA, S ;
COSTALL, B ;
NAYLOR, RJ .
NEUROPHARMACOLOGY, 1990, 29 (11) :1037-&
[7]   [H-3] ZACOPRIDE - LIGAND FOR THE IDENTIFICATION OF 5-HT3 RECOGNITION SITES [J].
BARNES, NM ;
COSTALL, B ;
NAYLOR, RJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1988, 40 (08) :548-551
[8]   STRATIFIED, RANDOMIZED, DOUBLE-BLIND COMPARISON OF INTRAVENOUS ONDANSETRON ADMINISTERED AS A MULTIPLE-DOSE REGIMEN VERSUS 2 SINGLE-DOSE REGIMENS IN THE PREVENTION OF CISPLATIN-INDUCED NAUSEA AND VOMITING [J].
BECK, TM ;
HESKETH, PJ ;
MADAJEWICZ, S ;
NAVARI, RM ;
PENDERGRASS, K ;
LESTER, EP ;
KISH, JA ;
MURPHY, WK ;
HAINSWORTH, JD ;
GANDARA, DR ;
BRICKER, LJ ;
KELLER, AM ;
MORTIMER, J ;
GALVIN, DV ;
HOUSE, KW ;
BRYSON, JC .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) :1969-1975
[9]   CHARACTERIZATION OF THE NOVEL 5-HT3 ANTAGONISTS MDL-73147EF (DOLASETRON MESILATE) AND MDL-74156 IN NG108-15 NEUROBLASTOMA X GLIOMA-CELLS [J].
BOEIJINGA, PH ;
GALVAN, M ;
BARON, BM ;
DUDLEY, MW ;
SIEGEL, BW ;
SLONE, AL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 219 (01) :9-13
[10]   COMMON PHARMACOLOGICAL AND PHYSICOCHEMICAL PROPERTIES OF 5-HT3 BINDING-SITES IN THE RAT CEREBRAL-CORTEX AND NG 108-15 CLONAL CELLS [J].
BOLANOS, FJ ;
SCHECHTER, LE ;
MIQUEL, MC ;
EMERIT, MB ;
RUMIGNY, JF ;
HAMON, M ;
GOZLAN, H .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (07) :1541-1550